Combination of Platelet-rich Plasma and Cyclooxygenase-2 Inhibitor Potently Stimulates Bone Marrow Stromal Cell Proliferation in Vitro

[1]  N. Kübler,et al.  Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. , 2004, International journal of oral and maxillofacial surgery.

[2]  T. Tözüm,et al.  Platelet-rich plasma: a promising innovation in dentistry. , 2003, Journal.

[3]  A. M. Simon,et al.  Cyclooxygenase-2 function is essential for bone fracture healing , 2003 .

[4]  H. Schliephake.  Bone growth factors in maxillofacial skeletal reconstruction , 2002 .

[5]  H. Herschman,et al.  Bone Morphogenetic Protein 2 Induces Cyclo‐oxygenase 2 in Osteoblasts via a Cbfa1 Binding Site: Role in Effects of Bone Morphogenetic Protein 2 In Vitro and In Vivo , 2002 .

[6]  A. M. Simon,et al.  Cyclo‐Oxygenase 2 Function Is Essential for Bone Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  E. Schwarz,et al.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. , 2002, The Journal of clinical investigation.

[8]  J. Hollinger,et al.  The biology of platelet-rich plasma. , 2001, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[9]  R Gordon,et al.  Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. , 2001, The Journal of pharmacology and experimental therapeutics.

[10]  R. Marx,et al.  Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[11]  J. Aubin,et al.  Advances in the osteoblast lineage. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[12]  H. Herschman,et al.  Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells. , 1997, Endocrinology.

[13]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[14]  G. Mundy.  Regulation of bone formation by bone morphogenetic proteins and other growth factors. , 1996, Clinical orthopaedics and related research.

[15]  H. Herschman.  Prostaglandin synthase 2. , 1996, Biochimica et biophysica acta.

[16]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.

[17]  H. Kawaguchi,et al.  Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. , 1993, The Journal of biological chemistry.

[18]  V. Goldberg,et al.  Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic. , 1991, Biomaterials.

[19]  T. Suda,et al.  Transforming growth factor-beta modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages. , 1990, Bone and mineral.

[20]  S. D'souza,et al.  Effects of transforming growth factors β1 and β2 on a mouse clonal, osteoblastlike cell line MC3T3‐E1 , 1989 .

[21]  E. Canalis,et al.  Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. , 1987, The Journal of biological chemistry.

[22]  L. Raisz,et al.  Effects of parathyroid hormone and cortisol on prostaglandin production by neonatal rat calvaria in vitro. , 1985, Endocrine research.

[23]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.